Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies.

Condition:   Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer Intervention:   Drug: Combination of Palbociclib and aromatase inhibitor (Letrozole or Anastrozole) Sponsors:   International Cancer Research Group, United Arab Emirates;   King Saud University Medical City, Riyadh, Saudi Arabia;   Max-Planck-Institut für Quantenoptik (MPQ), and Faculty of Physics at Ludwig-Maximilians-Universität München (LMU), Garching, Germany;   King Abdallah University for Scie nce and Technology (KAUST), Thuwal, Saudi Arabia. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials